Stock Events

Stock Events

AMGEN 

$443.65
3910
-$0.47-0.11% 11:44 Today

Statistics

Day High
445.82
Day Low
438.08
52W High
447.03
52W Low
269.77
Volume
1,842,232
Avg. Volume
2,703,012
Mkt Cap
240.11B
P/E Ratio
25.32
Dividend Yield
2.27%
Dividend
10.08

Upcoming

Dividends

2.27%Dividend Yield
Sep 26
$2.52
Jun 26
$2.52
Mar 26
$2.52
Dec 25
$2.38
Sep 25
$2.38
10Y Growth
10.59%
5Y Growth
7.84%
3Y Growth
6.38%
1Y Growth
5.83%

Earnings

3NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
4.27
4.94
5.62
6.29
Expected EPS
5.785453
Actual EPS
N/A

Financials

20.98%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
36.75BRevenue
7.71BNet Income

Analyst Ratings

397.65Average Price Target
The highest estimate is 460.00.
From 17 ratings within the last 6 months. This is not an investment recommendation.
Buy
35%
Hold
65%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AMGN. It's not an investment recommendation.
Abbvie
945
ABBV
Microsoft
863
MSFT
Apple
825
AAPL
Realty Income
775
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences competes in the biopharmaceutical sector focusing on antiviral drugs, similar therapeutic areas as Amgen.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie operates in the same biopharmaceutical space, with a strong presence in immunology and oncology, directly competing with Amgen's product lines.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is a major player in the biopharmaceutical industry, with a focus on cancer and immune system disorders, overlapping with Amgen's market.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical company with a broad range of products that compete across several of Amgen's key therapeutic areas.
Merck
MRK
Mkt Cap366B
Merck & Co. focuses on pharmaceuticals including oncology, vaccines, and animal health, competing with Amgen in the oncology and biologic drugs market.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the immunology and oncology sectors, similar to Amgen.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals specializes in biopharmaceuticals, particularly in monoclonal antibodies, a direct competitor to Amgen's biologic treatments.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that competes with Amgen in several areas, including biopharmaceuticals and generic drugs.
Rogers
ROG
Mkt Cap2.24B
Roche Holding AG, with its strong focus on oncology and immunotherapy, competes directly with Amgen in the biopharmaceutical and diagnostics sectors.
Sanofi
SNY
Mkt Cap107.39B
Sanofi operates globally in the pharmaceutical sector, with a focus on diabetes, oncology, and rare diseases, areas where Amgen also has significant interests.

About

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis, which has been further strengthened with the launch of new drugs in blood cancers (Blincyto) and solid tumors (Imdelltra). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Show more...
CEO
Robert A. Bradway
Employees
31500
Country
United States
ISIN
US0311621009
WKN
000867900

Listings

XNAS
US
AMGN
F
DE
AMG0.F
STU
DE
AMG.STU
SN
CL
AMGN.SN

0 Comments

Share your thoughts

FAQ

What is AMGEN stock price today?▼
The current price of AMGN is $443.65 USD — it has decreased by -0.11% in the past 24 hours. Watch AMGEN stock price performance more closely on the chart.
What is AMGEN stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange AMGEN stocks are traded under the ticker AMGN.
Is AMGEN stock price growing?▼
AMGN stock has risen by +2.71% compared to the previous week, the month change is a +13.87% rise, over the last year AMGEN has showed a +58.56% increase.
What is AMGEN market cap?▼
Today AMGEN has the market capitalization of 240.11B
When is the next AMGEN earnings date?▼
AMGEN is going to release the next earnings report on November 03, 2026.
What were AMGEN earnings last quarter?▼
AMGN earnings for the last quarter are 6.29 USD per share, whereas the estimation was 5.62 USD resulting in a +11.97% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is AMGEN revenue for the last year?▼
AMGEN revenue for the last year amounts to 36.75B USD.
What is AMGEN net income for the last year?▼
AMGN net income for the last year is 7.71B USD.
Does AMGEN pay dividends?▼
Yes, AMGN dividends are paid quarterly. The last dividend per share was 2.52 USD. As of today, Dividend Yield (FWD)% is 2.27%.
How many employees does AMGEN have?▼
As of September 04, 2026, the company has 31,500 employees.
In which sector is AMGEN located?▼
AMGEN operates in the Health & Wellness sector.
When did AMGEN complete a stock split?▼
AMGEN has not had any recent stock splits.
Where is AMGEN headquartered?▼
AMGEN is headquartered in THOUSAND OAKS, United States.